HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rituximab and intense chemotherapy in a patient with defective cell mediated immunity due to cartilage-hair hypoplasia and Burkitt lymphoma.

AuthorsBeth A Speckhart, Eric Bugaieski, Reuben Antony, Karen S Fernandez
JournalPediatric blood & cancer (Pediatr Blood Cancer) Vol. 67 Issue 7 Pg. e28259 (07 2020) ISSN: 1545-5017 [Electronic] United States
PMID32400949 (Publication Type: Case Reports, Letter)
Chemical References
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone
  • Methotrexate
Topics
  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Burkitt Lymphoma (complications, drug therapy, immunology, pathology)
  • Cyclophosphamide (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Female
  • Hair (abnormalities, immunology, pathology)
  • Hirschsprung Disease (complications, drug therapy, immunology, pathology)
  • Humans
  • Immunity, Cellular (drug effects)
  • Immunocompromised Host (drug effects)
  • Methotrexate (administration & dosage)
  • Osteochondrodysplasias (complications, congenital, drug therapy, immunology, pathology)
  • Prednisone (administration & dosage)
  • Primary Immunodeficiency Diseases (complications, drug therapy, immunology, pathology)
  • Prognosis
  • Rituximab (administration & dosage)
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: